ADmit Therapeutics announces that it has successfully passed the annual external audit, demonstrating that the medical device quality management system and its effectiveness are adequately maintained. We are pleased to share that, in our tireless effort to pursue excellence in quality, the scope of our ISO13485:2016 certification has been expanded to include the manufacturing of our products: Design and Development, Production of in-vitro diagnostic reagents for genetic analysis of epigenetic changes. Design and Development, Production and Service of in-vitro diagnostic software for nucleic acid analysis (NGS data analysis for mitochondrial DNA methylation patterns).
